Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 5, 2014, Pages 626-632

  Basset Seguin, N ^a   Bissonnette, R ^b   Girard, C ^c   Haedersdal, M ^d   Lear, J T ^e   Paul, C ^f   Piaserico, S ^g  

^a SAINT LOUIS HOSPITAL   (France)

^b INNOVADERM RESEARCH   (Canada)

^c HÔPITAL SAINT ELOI   (France)

^d BISPEBJERG HOSPITAL   (Denmark)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f UNIVERSITÉ PAUL SABATIER   (France)

^g UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; AMINOLEVULINIC ACID;

ANALGESIA; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER RECURRENCE; CANCER THERAPY; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONSENSUS DEVELOPMENT; COST EFFECTIVENESS ANALYSIS; DERMATOLOGIST; DISEASE SEVERITY; FOLLOW UP; HUMAN; NODULAR BASAL CELL CARCINOMA; PERSONAL EXPERIENCE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RISK FACTOR; SENSITIZATION; SUPERFICIAL BASAL CELL CARCINOMA; THERAPY EFFECT; ADULT; AGED; CARCINOMA, BASAL CELL; CHILD; COMPLICATION; CONSENSUS; MIDDLE AGED; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; AMINOLEVULINIC ACID; BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; CHILD; CONSENSUS; HUMANS; MIDDLE AGED; PAIN MANAGEMENT; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

EID: 84899118727     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12150     Document Type: Article

References (44)

1. Bath-Hextall FJ, Perkins W, Bong J, Williams HC,. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2007; (1): CD003412.
2. Lo Muzio L,. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis 2008; 3: 32.
3. Evans DG, Howard E, Giblin C, et al,. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 2010; 152: 327-332.
4. Gorlin RJ,. Nevoid basal cell carcinoma syndrome. Dermatol Clin 1995; 13: 113-125.
5. Kimonis VE, Goldstein AM, Pastakia B, et al,. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997; 69: 299-308.
6. Parren LJ, Frank J,. Hereditary tumour syndromes featuring basal cell carcinomas. Br J Dermatol 2011; 165: 30-34.
7. van der Geer S, Ostertag JU, Krekels GA,. Treatment of basal cell carcinomas in patients with nevoid basal cell carcinoma syndrome. J Eur Acad Dermatol Venereol 2009; 23: 308-313.
8. Sterry W,. Guidelines: the management of basal cell carcinoma. Eur J Dermatol 2006; 16: 467-475.
9. Yiu WK, Basco MT, Aruny JE, Cheng SW, Sumpio BE,. Cryosurgery: a review. Int J Angiol 2007; 16: 1-6.
10. Love WE, Bernhard JD, Bordeaux JS,. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol 2009; 145: 1431-1438.
11. Kagy MK, Amonette R,. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg 2000; 26: 577-579.
12. Stokfleth E, Meyer T, Benninghoff B, et al,. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002; 138: 1498-1502.
13. Heikkinen AK, Susitaival P,. Severe systemic reaction to topical Imiquimod. Acta Derm Venereol 2011; 91: 594-595.
14. Rhodes LE, de Rie M, Enström Y, et al,. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004; 140: 17-23.
15. Szeimies RM, Ibbotson S, Murrell DF, et al,. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008; 22: 1302-1311.
16. Basset-Seguin N, Ibbotson SH, Emtestam L, et al,. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008; 18: 547-553.
17. Rhodes LE, de Rie MA, Leifsdottir R,. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007; 143: 1131-1136.
18. Braathen LR, Szeimies RM, Basset-Seguin N, et al,. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007; 56: 125-143.
19. Bree AF, Shah MR, BCNS Colloquium Group. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am J Med Genet A 2011; 155A: 2091-2097.
20. Fai D,. MAL-PDT for the treatment of multiple basal cell carcinomas in a patient with Gorlin-Goltz Syndrome. J Invest Dermatol 2006; 126: S34.
21. Van Den Bossche K, Strobbe T, Dierckxsens L, Lambert J, Brochez L, Verhaeghe E,. Photodynamic therapy in multiple basal cell carcinoma in a patient with Gorlin syndrome. Ned Tijdschr Dermatol Venereol 2008; 18: 301-303.
22. Mougel F, Debarbieux S, Ronger-Savlé S, Dalle S, Thomas L,. Methylaminolaevulinate photodynamic therapy in patients with multiple basal cell carcinomas in the setting of Gorlin-Goltz syndrome or after radiotherapy. Dermatology 2009; 219: 138-142.
23. Loncaster J, Swindell R, Slevin F, Sheridan L, Allan D, Allan E,. Efficacy of photodynamic therapy as a treatment for Gorlin syndrome-related basal cell carcinomas. Clin Oncol (R Coll Radiol) 2009; 21: 502-508.
24. Neves DR, Ramos DG, Magalhães GM, Rodrigues Rda C, Souza JB,. Photodynamic therapy for treatment of multiple lesions on the scalp in nevoid basal cell carcinoma syndrome: case report. An Bras Dermatol 2010; 85: 545-548.
25. Huguier V, Wierzbicka-Hainaut E, Fray J, Guillet G, Dagrégorio G,. Gorlin syndrome: photodynamic therapy, as a useful adjunct to surgery. Ann Chir Plast Esthet 2012; 57: 173-176.
26. Segura S, Puig S, Carrera C, Lecha M, Borges V, Malvehy J,. Non-invasive management of non-melanoma skin cancer in patients with cancer predisposition genodermatosis: a role for confocal microscopy and photodynamic therapy. J Eur Acad Dermatol Venereol 2011; 25: 819-827.
27. Pauwels C, Mazereeuw-Hautier J, Basset-Seguin N, et al,. Topical methyl aminolevulinate photodynamic therapy for management of basal cell carcinomas in patients with basal cell nevus syndrome improves patient's satisfaction and reduces the need for surgical procedures. J Eur Acad Dermatol Venereol 2011; 25: 861-864.
28. Girard C, Debu A, Bessis D, Blatière V, Dereure O, Guillot B,. Treatment of Gorlin syndrome (nevoid basal cell carcinoma syndrome) with methylaminolevulinate photodynamic therapy in seven patients, including two children: interest of tumescent anesthesia for pain control in children. J Eur Acad Dermatol Venereol 2013; 27: e171-175.
29. Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA,. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006; 86: 25-28.
30. Kaviani A, Ataie-Fashtami L, Fateh M,. Photodynamic therapy of head and neck basal cell carcinoma according to different clinicopathologic features. Lasers Surg Med 2005; 36: 377-382.
31. Fantini F, Greco A, Del Giovane C, et al,. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. J Eur Acad Dermatol Venereol 2011; 25: 896-901.
32. Angell-Petersen E, Sørensen R, Warloe T, et al,. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 2006; 126: 265-271.
33. Bashkatov AN, Genina EA, Kochubey VI, Tuchin VV,. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. J Phys D: Appl Phys 2005; 38: 2543-2555.
34. Stangeland KZ, Kroon S,. Cold air analgesia as pain reduction during photodynamic therapy of actinic keratoses. J Eur Acad Dermatol Venereol 2012; 26: 849-854.
35. Kaae J, Philipsen PA, Haedersdal M, Wulf HC,. Immediate whealing urticaria in red light exposed areas during photodynamic therapy. Acta Derm Venereol 2008; 88: 480-483.
36. Korshøj S, Sølvsten H, Erlandsen M, Sommerlund M,. Frequency of sensitization to methyl aminolaevulinate after photodynamic therapy. Contact Dermatitis 2009; 60: 320-324.
37. Hohwy T, Andersen KE, Sølvsten H, Sommerlund M,. Allergic contact dermatitis to methyl aminolevulinate after photodynamic therapy in 9 patients. Contact Dermatitis 2007; 57: 321-323.
38. Mroz P, Hamblin MR,. The immunosuppressive side of PDT. Photochem Photobiol Sci 2011; 10: 751-758.
39. Castano AP, Mroz P, Hamblin MR,. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 2006; 6: 535-545.
40. van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ,. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 2003; 207: 105-113.
41. Hogan BV, Peter MB, Shenoy HG, Horgan K, Hughes TA,. Surgery induced immunosuppression. Surgeon 2011; 9: 38-43.
42. Caty V, Liu Y, Viau G, Bissonnette R,. Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice. Br J Dermatol 2006; 154: 740-742.
43. Basset-Seguin N, Baumann Conzett K, Gerritsen MJP,. Photodynamic therapy for actinic keratosis in organ transplant patients. J Eur Acad Dermatol Venereol 2013; 27: 57-66.
44. Wolfe CM, Green WH, Cognetta AB Jr, Hatfield HK,. A possible chemopreventive role for photodynamic therapy in Gorlin syndrome: a report of basal cell carcinoma reduction and review of literature. Australas J Dermatol 2013; 54: 64-68.